药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brinzolamide
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Mepyramine.
Brinzolamide
Encainide
The metabolism of Encainide can be decreased when combined with Mepyramine.
Brinzolamide
Revefenacin
The metabolism of Revefenacin can be decreased when combined with Mepyramine.
Brinzolamide
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Mepyramine.
Brinzolamide
Fesoterodine
The metabolism of Fesoterodine can be decreased when combined with Mepyramine.
Brinzolamide
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Mepyramine.
Brinzolamide
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Mepyramine.
Brinzolamide
Relugolix
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Relugolix.
Brinzolamide
Fostemsavir
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fostemsavir.
Brinzolamide
Inotersen
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Inotersen.
Brinzolamide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pipemidic acid.
Brinzolamide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Rufloxacin.
Brinzolamide
Lidoflazine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lidoflazine.
Brinzolamide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Piromidic acid.
Brinzolamide
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Acetyldigoxin.
Brinzolamide
Lorajmine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lorajmine.
Brinzolamide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxolinic acid.
Brinzolamide
Prajmaline
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Prajmaline.
Brinzolamide
Bencyclane
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bencyclane.
Brinzolamide
Cibenzoline
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cibenzoline.